Elvitegravir (Viteka)

Published October 15, 2012; Updated September 2014
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-02
Selected Reference
11. Abram ME, Hluhanich RM, Goodman DD, et al. Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. Antimicrob Agents Chemother. 2013 Jun;57(6):2654-63.